Molecular Imaging Using Endogenous Cellular Proteins

Abstract

Abstract:

Amide proton transfer (APT) imaging is a novel molecular MRI technique that generates image contrast based on endogenous cellular proteins in tissue. Theoretically, the APT-MRI signal depends primarily on the mobile amide proton concentration and amide proton exchange rates (which are related to tissue pH). The APT technique has been used for non-invasive pH imaging in stroke (where pH drops) and protein content imaging in tumor (where many proteins are overexpressed). It has been demonstrated recently in animal models that the APT-MRI signal is also a unique imaging biomarker to distinguish between radiation necrosis and active tumor. In this paper, we will briefly introduce the basic principles of APT imaging and review its applications in stroke and brain tumor studies in animal models and patients.

Key words: amide proton transfer (APT), pH imging, molecular imaging, stroke, brain tumor

CLC Number:

O482.53

ZHOU Jin-yuan1,2*, HONG Xiao-hua1,3. Molecular Imaging Using Endogenous Cellular Proteins[J]. Chinese Journal of Magnetic Resonance.

References

[1] Yu Kai-chao(俞开潮), Wang Guo-ping(王国平), Ding Shang-wu(丁尚武), et al. Recent progress in the development of contrast agents used in magnetic resonance imaging(用于磁共振成像对比增强的造影剂研发进展)[J]. Chinese J Magn Reson(波谱学杂志), 2004, 21(4): 505-525.

[2] Yang Li-qin(杨丽琴), Lin Fu-chun(林富春), Lei Hao(雷皓). Resting state functional connectivity in brain studies by fMRI approach(静息状态下脑功能连接的磁共振成像研究)[J]. Chinese J Magn Reson(波谱学杂志), 2010, 27(3): 326-340.

[3] Verma R, Zacharaki E I, Ou Y, et al. Multiparametric tissue characterization of brain neoplasms and their recurrence using pattern classification of MR images[J]. Acad Radiol, 2008, 15: 966-977.

[4] Heiss W D, Raab P, Lanfermann H. Multimodality assessment of brain tumors and tumor recurrence[J]. J Nucl Med, 2011, 52(10): 1 585-1 600.

[5] Baird A E, Warach S. Magnetic resonance imaging of acute stroke[J]. J Cereb Blood Flow Metab, 1998, 18: 583-609.

[6] Wang Xiao-hong(王小红), Zhang Qin-ta(张钦塔), Lin Yan-qin(林雁勤), et al. Twodimensional localized magnetic resonance spectroscopy and its in vivo application(二维核磁共振定域谱及其在活体中的应用)\[J\]. Chinese J Magn Reson(波谱学杂志), 2011, 28(3): 419-436.

[7] Wang Qian-feng(王前锋）, Li Jian-qi（李建奇), Wu Dong-mei(吴东梅), et al. High-resolution diffusion-weighted imaging on small animals ona clinical 3 T MRI scanner(小动物高分辨扩散加权成像在临床MRI上的实现)[J]. Chinese J Magn Reson(波谱学杂志), 2012, 29(3): 372-378.

[8] Weissleder R, Moore A, Mahmood U, et al. In vivo magnetic resonance imaging of transgene expression[J]. Nature Med, 2000, 6: 351-354.

[9] Yu Kai-chao(俞开潮）, Lv Zhi-yong（吕志勇）, Yao Yao（姚遥）, et al. Recent progress in development of bio-active MRI contrast agents(生物激活磁共振成像造影剂的研究进展)[J]. Chinese J Magn Reson(波谱学杂志), 2010, 27(3): 355-368.

[10] Hobbs S K, Shi G, Homer R, et al. Magnetic resonance imaging-guided proteomics of human glioblastoma multiforme[J]. J Magn Reson Imag, 2003, 18: 530-536.

[11] Li J, Zhuang Z, Okamoto H, et al. Proteomic profiling distinguishes astrocytomas and identifies differential tumor markers[J]. Neurology, 2006, 66: 733-736.

[12] Wolff S D, Balaban R S. Magnetization transfer contrast (MTC) and tissue water proton relaxation in vivo[J\]. Magn Reson Med, 1989, 10: 135-144.

[13] Behar K L, Ogino T. Assignment of resonances in the ¹H spectrum of rat brain by two dimensional shift correlated and J-resolved NMR spectroscopy[J]. Magn Reson Med, 1991, 17: 285-303.

[14] Behar K L, Ogino T. Characterization of macromolecule resonances in the ¹H NMR spectrum of rat brain[J]. Magn Reson Med, 1993, 30: 38-44.

[15] Kauppinen R A, Kokko H, Williams S R. Detection of mobile proteins by proton nuclear magnetic resonance spectroscopy in the guinea pig brain ex vivo and their partial purification[J]. J Neurochem, 1992, 58: 967-974.

[16] Pfeuffer J, Tkac I, Provencher S W, et al. Toward an in vivo neurochemical profile: quantification of 18 metabolites in short-echo-time ¹H NMR spectra of the rat brain[J]. J Magn Reson, 1999, 141: 104-120.

[17] Wolff S D, Balaban R S. NMR imaging of labile proton exchange[J]. J Magn Reson, 1990, 86: 164-169.

[18] Guivel-Scharen V, Sinnwell T, Wolff S D, et al. Detection of proton chemical exchange between metabolites and water in biological tissues[J]. J Magn Reson, 1998, 133: 36-45.

[19] Ward K M, Aletras A H, Balaban R S. A new class of contrast agents for MRI based on proton chemical exchange dependent saturation transfer (CEST)[J]. J Magn Reson, 2000, 143: 79-87.

[20] Forsen S, Hoffman R A. Study of moderately rapid chemical exchange reactions by means of nuclear magnetic double resonance[J]. J Chem Phys, 1963, 39: 2 892-2 901.

[21] Zhou J, Payen J, Wilson D A, et al. Using the amide proton signals of intracellular proteins and peptides to detect pH effects in MRI[J]. Nature Med, 2003, 9: 1 085-1 090.

[22] Zhou J, van Zijl P C. Chemical exchange saturation transfer imaging and spectroscopy[J]. Progr NMR Spectr, 2006, 48: 109-136.

[23] Aime S, Crich S G, Gianolio E, et al. High sensitivity lanthanide(III) based probes for MR-medical imaging[J]. Coord Chem Rev, 2006, 250: 1 562-1 579.

[24] Sherry A D, Woods M. Chemical exchange saturation transfer contrast agents for magnetic resonance imaging[J]. Annu Rev Biomed Eng, 2008, 10: 391-411.

[25] Goffeney N, Bulte J W M, Duyn J, et al. Sensitive NMR detection of cationic-polymer-based gene delivery systems using saturation transfer via proton exchange[J]. J Am Chem Soc, 2001, 123: 8 628-8 629.

[26] Zhang S, Winter P, Wu K, et al. A novel europium(III)-based MRI contrast agent[J]. J Am Chem Soc, 2001, 123(7): 1 517-1 578.

[27] Aime S, Barge A, Delli Castelli D, et al. Paramagnetic Lanthanide(III) complexes as pH-sensitive chemical exchange saturation transfer (CEST) contrast agents for MRI applications[J]. Magn Reson Med, 2002, 47: 639-648.

[28] Schroder L, Lowery T J, Hilty C, et al. Molecular imaging using a targeted magnetic resonance hyperpolarized biosensor[J]. Science, 2006, 314: 446-449.

[29] Vinogradov E, Zhang S, Lubag A, et al. On-resonance low B1 pulses for imaging of the effects of PARACEST agents[J]. J Magn Reson, 2005, 176: 54-63.

[30] Zhang S, Zhu X, Chen Z, et al. Improvement in the contrast of CEST MRI via intermolecular double quantum coherences[J]. Phys Med Biol, 2008, 53: N287-N296.

[31] Kogan F, Singh A, Cai K, et al. Investigation of chemical exchange at intermediate exchange rates using a combination of chemical exchange saturation transfer (CEST) and spin-locking methods (CESTrho)[J]. Magn Reson Med, 2012, 68(1): 107-119.

[32] Jin T, Autio J, Obata T, et al. Spin-locking versus chemical exchange saturation transfer MRI for investigating chemical exchange process between water and labile metabolite protons\[J\]. Magn Reson Med, 2011, 65(5): 1 448-1 460.

[33] Ward K M, Balaban R S. Determination of pH using water protons and chemical exchange dependent saturation transfer (CEST)[J]. Magn Reson Med, 2000, 44: 799-802.

[34] Dagher A P, Aletras A, Choyke P, et al. Imaging of urea using chemical exchange-dependent saturation transfer at 1.5T[J]. J Magn Reson Imaging, 2000, 12: 745-748.

[35] Aime S, Delli Castelli D, Fedeli F, et al. A paramagnetic MRI-CEST agent responsive to lactate concentration[J]. J Am Chem Soc, 2002, 124: 9 364-9 365.

[36] Zhou J, Lal B, Wilson D A, et al. Amide proton transfer (APT) contrast for imaging of brain tumors[J]. Magn Reson Med, 2003, 50: 1 120-1 126.

[37] Zhou J, Blakeley J O, Hua J, et al. Practical data acquisition method for human brain tumor amide proton transfer (APT) imaging\[J\]. Magn Reson Med, 2008, 60: 842-849.

[38] Cai KJ, Haris M, Singh A, et al. Magnetic resonance imaging of glutamate\[J\]. Nature Med, 2012, 18(2): 302-306.

[39] Zhang S, Trokowski R, Sherry A D. A paramagnetic CEST agent for imaging glucose by MRI[J]. J Am Chem Soc, 2003, 125: 15 288-15 289.

[40] van Zijl P C M, Jones C K, Ren J, et al. MRI detection of glycogen in vivo by using chemical exchange saturation transfer imaging (glycoCEST)[J]. Proc Natl Acad Sci (USA), 2007, 104: 4 359-4 364.

[41] Ling W, Regatte R R, Navon G, et al. Assessment of glycosaminoglycan concentration in vivo by chemical exchange-ependent saturation transfer (gagCEST)[J]. Proc Natl Acad Sci (USA), 2008, 105: 2 266-2 270.

[42] Aime S, Carrera C, Delli Castelli D, et al. Tunable imaging of cells labelled with MRI-PARACEST agents[J]. Angew Chem Int Ed, 2005, 44: 1 813-1 815.

[43] Yoo B, Pagel M D. A PARACEST MRI contrast agent to detect enzyme activity\[J\]. J Am Chem Soc, 2006, 128: 14 032-14 033.

[44] Gilad A A, McMahon M T, Walczak P, et al. Artificial reporter gene providing MRI contrast based on proton exchange\[J\]. Nature Biot, 2007, 25: 217-219.

[45] Wuthrich K. NMR of proteins and nucleic acids (2nd ed)[M]. New York: John Wiley & Sons, 1986.

[46] Englander S W, Downer N W, Teitelbaum H. Hydrogen exchange\[J\]. Annu Rev Biochem, 1972, 41: 903-924.

[47] Hua J, Jones C K, Blakeley J, et al. Quantitative description of the asymmetry in magnetization transfer effects around the water resonance in the human brain[J]. Magn Reson Med, 2007, 58: 786-793.

[48] Zhou J, Wilson D A, Sun P Z, et al. Quantitative description of proton exchange processes between water and endogenous and exogenous agents for WEX, CEST, and APT experiments[J]. Magn Reson Med, 2004, 51: 945-952.

[49] Kintner D B, Anderson M E, Sailor K A, et al. In vivo microdialysis of 2-deoxyglucose 6-phosphate into brain: a novel method for the measurement of interstitial pH using 31P NMR[J]. J Neurochem, 1999, 72: 405-412.

[50] Griffiths J R. Are cancer cells acidic? [J]. Br J Cancer, 1991, 64: 425-427.

[51] Sun P Z, Zhou J, Sun W, et al. Detection of the ischemic penumbra using pH-weighted MRI[J]. J Cereb Blood Flow Metab, 2007, 27: 1 129-1 136.

[52] Jokivarsi K T, Grohn H I, Grohn O H, et al. Proton transfer ratio, lactate, and intracellular pH in acute cerebral ischemia[J]. Magn Reson Med, 2007, 57: 647-653.

[53] Jokivarsi K T, Hiltunen Y, Tuunanen P I, et al. Correlating tissue outcome with quantitative multiparametric MRI of acute cerebral ischemia in rats[J]. J Cereb Blood Metab, 2010, 30: 415-427.

[54] Wei Mao-bin(韦茂彬）, Shen Zhi-wei(沈智威), Xiao Gang(肖刚), et al. Study of magnetic resonance imaging at 1.5 Tesla based on pH-sensitive magnetization transfer technology(基于pH值敏感的磁化传递技术在1.5 T磁共振成像上的研究)[J]. Chinese J Magn Reson Imag(磁共振成像), 2012, 3: 40-43.

[55] Zhao X, Wen Z, Huang F, et al. Saturation power dependence of amide proton transfer image contrasts in human brain tumors and strokes at 3 T[J]. Magn Reson Med, 2011, 66: 1 033-1 041.

[56] Salhotra A, Lal B, Laterra J, et al. Amide proton transfer imaging of 9L gliosarcoma and human glioblastoma xenografts[J]. NMR Biomed, 2008, 21: 489-497.

[57] Jones C K, Schlosser M J, van Zijl P C, et al. Amide proton transfer imaging of human brain tumors at 3 T[J]. Magn Reson Med, 2006, 56: 585-592.

[58] Wen Z, Hu S, Huang F, et al. MR imaging of high-grade brain tumors using endogenous protein and peptide-based contrast[J]. Neuroimage, 2010, 51: 616-622.

[59] Segall H D, Destian S, Nelson M D. CT and MR imaging in malignant gliomas. In: Apuzzo MLJ, editor. Malignant cerebral glioma[M]. Park Ridge, IL: American Association of Neurological Surgeons, 1990. 63-78.

[60] Scott J N, Brasher P M, Sevick R J, et al. How often are nonenhancing supratentorial gliomas malignant? A population study[J]. Neurology, 2002, 59: 947-949.

[61] Knopp E A, Cha S, Johnson G, et al. Glial neoplasms: dynamic contrast-enhanced T*₂-weighted MR imaging[J]. Radiology, 1999, 211: 791-798.

[62] Howe F A, Barton S J, Cudlip S A, et al. Metabolic profiles of human brain tumors using quantitative in vivo ¹H magnetic resonance spectroscopy[J]. Magn Reson Med, 2003, 49: 223-232.

[63] Sun P Z, Murata Y, Lu J, et al. Relaxation-compensated fast multislice amide proton transfer (APT) imaging of acute ischemic stroke[J]. Magn Reson Med, 2008, 59: 1 175-1 182.

[64] Zhu H, Jones C K, van Zijl P C M, et al. Fast 3D chemical exchange saturation transfer (CEST) imaging of the human brain[J]. Magn Reson Med, 2010, 64: 638-644.

[65] Jones C K, Polders D, Hua J, et al. In vivo 3D whole-brain pulsed steady state chemical exchange saturation transfer at 7T [J]. Magn Reson Med, 2012, 67: 1 579-1 589.

[66] Zhou J, Zhu H, Lim M, et al. Assessment of brain tumors at the protein level with amide proton transfer MRI[C]. Chicago: Proc 97th Ann Meeting RSNA, 2011, MSVN31-11.

[67] Keupp J, Baltes C, Harvey P R, et al. Parallel RF transmission based MRI technique for highly sensitive detection of amide proton transfer in the human brain[C]. Montreal: Proc 19th Annual Meeting ISMRM, 2011, 710.

[68] Wen P Y, Macdonald D R, Reardon D A, et al. Updated response assessment criteria for high-grade gliomas: response assessment in neuro-oncology working group[J]. J Clin Oncol, 2010, 28: 1 963-1 972.

[69] Kumar A J, Leeds N E, Fuller G N, et al. Malignant gliomas: MR imaging spectrum of radiation therapy- and chemotherapy-induced necrosis of the brain after treatment[J]. Radiology, 2000, 217: 377-384.

[70] Stupp R, Mason W P, van den Bent M J, et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma[J]. N Engl J Med, 2005, 352: 987-996.

[71] Brandes A A, Tosoni A, Spagnolli F, et al. Disease progression or pseudoprogression after concomitant radiochemotherapy treatment: Pitfalls in neurooncology[J]. NeuroOncology, 2008, 10: 361-367.

[72]Zhou J, Tryggestad E, Wen Z, et al. Differentiation between glioma and radiation necrosis using molecular magnetic resonance imaging of endogenous proteins and peptides[J]. Nature Med, 2011, 17: 130-134.